Apr 29, 2025 · Qelbree is a once-a-day treatment for attention deficit hyperactivity disorder (ADHD) in adults and children 6 years of age and older. Qelbree is a non-stimulant ADHD medicine that may …

Qelbree ® (viloxazine extended-release capsules) is a prescription medicine used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in adults and children 6 years and older.

Qelbree® (viloxazine extended-release capsules) is a non-stimulant ADHD treatment option for adults & children aged 6-17. Get resources & see Boxed Warning.

Learn how Qelbree for ADHD works, its benefits, side effects, and what to expect from this non-stimulant medication option.

The efficacy of Qelbree in the treatment of ADHD in adults 18 to 65 years of age was evaluated in a short-term, randomized, placebo-controlled, flexible-dose monotherapy trial (Study 4).

Oct 10, 2022 · Viloxazine (Qelbree) is a selective norepinephrine reuptake inhibitor labeled for the treatment of attention-deficit/hyperactivity disorder (ADHD) in adults and children older than six years. 1

Jul 21, 2024 · Qelbree (viloxazine) is commonly used to treat attention deficit hyperactivity disorder (ADHD). Qelbree may also be used for other conditions as determined by your healthcare provider.

What is Qelbree® and what does it treat? Viloxazine is a prescription medication that is used to treat individuals with attention-deficit hyperactivity disorder (ADHD).

What is the most important information I should know about QELBREE? QELBREE can cause serious side effects, including: • Increased risk of suicidal thoughts or actions. QELBREE may increase …

Qelbree (Generic Name: viloxazine) is a non-stimulant ADHD medication containing a serotonin norepinephrine modulating agent approved by the FDA to treat attention deficit hyperactivity disorder …